Zinc acetate
decreases
Common Cold
(BioMindmap Proof Quality is Acceptable.)
Zinc acetate
decreases
Common Cold
(BioMindmap Proof Quality is Acceptable.)
3.6
ValidityScore
Valid or Invalid?
Duration and severity of symptoms
-
2008RCT
-
Prasad AS, et al. -
«RESULTS: Compared with the placebo group, the zinc group had a shorter mean overall duration of cold (4.0 vs. 7.1 days; P < .0001) and shorter durations of cough (2.1 vs. 5.0 days; P < .0001) and nasal discharge (3.0 vs. 4.5 days, P = .02) Blinding of subjects was adequate, and adverse effects were comparable in the 2 groups. Symptom severity scores were decreased significantly in the zinc group. Mean changes in plasma levels of zinc, sIL-1ra, and ICAM-1 differed significantly between groups.
CONCLUSION: Administration of zinc lozenges was associated with reduced duration and severity of cold symptoms. We related the improvement in cold symptoms to the antioxidant and anti-inflammatory properties of zinc.» - Dose: 13,3 mg every 2-3h while awake
- Organism: Humans
- Notable Magnitude of Effect.
-
Comments:
A peer review of a nestarenie.ru post
Probably rhinoviruses - Found At: https://nestarenie.ru/aczetat-czinka.html
-
ranked
added it
1 year ago
on May 9, 2020